recurrent astrocytoma – Talk Bio

Actionable Insights Powered by AI

NeOnc Technologies Reports Updated Clinical Results for Intranasal NEO100

22 hours ago talkbio0Tagged Central Nervous System Neoplasms, clinical results, Compassionate Use, Intranasal approach, NEO100, NeOnc Technologies, NTHI, Overall Survival, Phase 1/2a trial, radiographic remission, recurrent astrocytoma, World Health Organization

NeOnc Technologies; NTHI; NEO100; intranasal NEO100; updated clinical results; recurrent astrocytoma; WHO Grade III/IV; radiographic remission; overall survival; compassionate use; Phase 1/2a trial; CNS cancers